Financial Ratios

APOLLO HOSPITALS ENTERPRISE LTD.

NSE : APOLLOHOSPBSE : 508869ISIN CODE : INE437A01024Industry : Hospital & Healthcare ServicesHouse : Apollo Hospitals
BSE6205.400.3 (+0 %)
PREV CLOSE ( ) 6205.10
OPEN PRICE ( ) 6222.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2135
TODAY'S LOW / HIGH ( )6175.45 6222.90
52 WK LOW / HIGH ( )4727 6871.3
NSE6207.601.4 (+0.02 %)
PREV CLOSE( ) 6206.20
OPEN PRICE ( ) 6210.00
BID PRICE (QTY) 6207.60 (5)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 216573
TODAY'S LOW / HIGH( ) 6175.00 6219.95
52 WK LOW / HIGH ( )4726 6874.45
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)75.4439.81-1.8433.7821.75
   CEPS(Rs)100.9465.0827.4668.4343.30
   DPS(Rs)15.0011.753.006.006.00
   Book NAV/Share(Rs)481.56424.94361.72286.52278.99
   Tax Rate(%)11.6332.8334.6531.0934.53
Margin Ratios
   Core EBITDA Margin(%)25.7723.2815.2314.3812.19
   EBIT Margin(%)22.4717.986.4411.318.76
   Pre Tax Margin(%)18.8113.98-0.876.975.55
   PAT Margin (%)16.639.39-0.574.803.63
   Cash Profit Margin (%)22.2515.358.499.727.23
Performance Ratios
   ROA(%)9.085.12-0.244.613.39
   ROE(%)16.6410.12-0.5711.957.99
   ROCE(%)17.4314.044.1015.5310.58
   Asset Turnover(x)0.550.550.430.960.93
   Sales/Fixed Asset(x)0.870.850.611.471.69
   Working Capital/Sales(x)3.422.693.0726.3322.53
Efficiency Ratios
   Fixed Capital/Sales(x)1.151.181.630.680.59
   Receivable days45.9960.7085.1034.9436.32
   Inventory Days6.8610.6935.9923.6424.08
   Payable days126.12142.16235.4044.5142.18
Valuation Parameters
   PER(x)57.12113.440.0033.6956.13
   PCE(x)42.6969.39105.7116.6328.20
   Price/Book(x)8.9510.638.033.974.38
   Yield(%)0.350.260.100.530.49
   EV/Net Sales(x)9.7210.899.371.902.39
   EV/Core EBITDA(x)34.5945.2959.7513.0819.37
   EV/EBIT(x)43.2560.58145.5816.8327.32
   EV/CE(x)5.165.724.061.682.15
   M Cap / Sales9.5010.658.971.622.04
Growth Ratio
   Net Sales Growth(%)6.9931.04-52.4817.4916.06
   Core EBITDA Growth(%)25.00100.88-48.8138.4022.33
   EBIT Growth(%)33.75265.92-72.9751.7028.09
   PAT Growth(%)89.482268.56-105.6155.2829.85
   EPS Growth(%)89.482268.54-105.4455.2829.78
Financial Stability Ratios
   Total Debt/Equity(x)0.250.330.440.790.83
   Current Ratio(x)2.532.912.001.191.23
   Quick Ratio(x)2.462.781.860.830.88
   Interest Cover(x)6.144.490.882.602.73
   Total Debt/Mcap(x)0.030.030.050.200.19

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.